Fifth Third Wealth Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Fifth Third Wealth Advisors LLC
- $2.71 Trillion
- Q3 2025
A detailed history of Fifth Third Wealth Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 1,800 shares of VRTX stock, worth $766,026. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,800
Previous 1,826
1.42%
Holding current value
$766,026
Previous $813 Million
13.28%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,784Shares Held
236MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$12.2 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$10.2 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.07 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.86 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.01 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $109B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...